UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

Mechanism of phospho-ubiquitin-induced PARKIN activation

Nature (London), 2015-08, Vol.524 (7565), p.370-374

2015

Link zum Volltext

Verfügbarkeit prüfen

The deubiquitinase OTUD1 regulates immunoglobulin production and proteasome inhibitor sensitivity in multiple myeloma

Nature communications, 2022-11, Vol.13 (1), p.6820-6820, Article 6820

2022

Link zum Volltext

Verfügbarkeit prüfen

Assembly and Specific Recognition of K29- and K33-Linked Polyubiquitin

Molecular cell, 2015-04, Vol.58 (1), p.95-109

2015

Link zum Volltext

Verfügbarkeit prüfen

Limited efficacy of daratumumab in multiple myeloma with extramedullary disease

Leukemia, 2022-01, Vol.36 (1), p.288-291

2022

Link zum Volltext

Verfügbarkeit prüfen

Length-Dependent Translation Efficiency of ER-Destined Proteins

Current issues in molecular biology, 2023-08, Vol.45 (8), p.6717-6727

2023

Link zum Volltext

Verfügbarkeit prüfen

Multiple regulatory roles of the mouse transmembrane adaptor protein NTAL in gene transcription and mast cell physiology

PloS one, 2014-08, Vol.9 (8), p.e105539-e105539

2014

Link zum Volltext

Verfügbarkeit prüfen

Intercellular Mitochondrial Transfer in the Tumor Microenvironment

Cancers, 2020-07, Vol.12 (7), p.1787

2020

Link zum Volltext

Verfügbarkeit prüfen

P805: EXTRAMEDULLARY MULTIPLE MYELOMA: MOLECULAR PATHOGENESIS AND NOVEL THERAPEUTIC TARGETS

HemaSphere, 2023-08, Vol.7 (S3), p.e003730a-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility

Journal of translational medicine, 2023-03, Vol.21 (1), p.197-197, Article 197

2023

Link zum Volltext

Verfügbarkeit prüfen

Venetoclax: A new wave in hematooncology

Experimental hematology, 2018-05, Vol.61, p.10-25

2018

Link zum Volltext

Verfügbarkeit prüfen

Deubiquitinase OTUD1 Resolves Stalled Translation on polyA and Rare Codon Rich mRNAs

Molecular and cellular biology, 2022-12, Vol.42 (12), p.e0026522-e0026522

2022

Link zum Volltext

Verfügbarkeit prüfen

Transcriptome Analysis of Diffuse Large B-Cell Lymphoma Cells Inducibly Expressing MyD88 L265P Mutation Identifies Upregulated CD44, LGALS3, NFKBIZ, and BATF as Downstream Targets of Oncogenic NF-κB Signaling

International journal of molecular sciences, 2023-03, Vol.24 (6), p.5623

2023

Link zum Volltext

Verfügbarkeit prüfen

Loss of PPP2R2A inhibits homologous recombination DNA repair and predicts tumor sensitivity to PARP inhibition

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24), p.6414-6424

2012

Link zum Volltext

Verfügbarkeit prüfen

The transmembrane adaptor protein NTAL signals to mast cell cytoskeleton via the small GTPase Rho

European journal of immunology, 2010-11, Vol.40 (11), p.3235-3245

2010

Link zum Volltext

Verfügbarkeit prüfen

A Bird's-Eye View of Cell Sources for Cell-Based Therapies in Blood Cancers

Cancers, 2020-05, Vol.12 (5), p.1333

2020

Link zum Volltext

Verfügbarkeit prüfen

Identification of Deubiquitinase OTUD1 As a Novel Player in Resistance of Multiple Myeloma to Bortezomib

Blood, 2019-11, Vol.134 (Supplement_1), p.5526-5526

2019

Link zum Volltext

Verfügbarkeit prüfen

Effect of Daratumumab-Containing Induction on CD34+ Hematopoietic Stem Cells before Autologous Stem Cell Transplantation in Multiple Myeloma

Blood, 2021-11, Vol.138 (Supplement 1), p.2764-2764

2021

Link zum Volltext

Verfügbarkeit prüfen

Active site alanine mutations convert deubiquitinases into high‐affinity ubiquitin‐binding proteins

EMBO reports, 2018-10, Vol.19 (10), p.n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

Insight into the mechanism of CD34+ cell mobilisation impairment in multiple myeloma patients treated with anti‐CD38 therapy

British journal of haematology, 2024-04, Vol.204 (4), p.1439-1449

2024

Link zum Volltext

Verfügbarkeit prüfen

Single‐agent venetoclax induces MRD‐negative response in relapsed primary plasma cell leukemia with t(11;14)

American journal of hematology, 2019-01, Vol.94 (1), p.E35-E37

2019

Link zum Volltext

Verfügbarkeit prüfen

Selection, Expansion, and Unique Pretreatment of Allogeneic Human Natural Killer Cells with Anti-CD38 Monoclonal Antibody for Efficient Multiple Myeloma Treatment

Cells (Basel, Switzerland), 2021-04, Vol.10 (5), p.967

2021

Link zum Volltext

Verfügbarkeit prüfen

Identification of Molecular Mechanisms Responsible for the Development of Extramedullary Disease in Myeloma and Potential Novel Therapeutic Targets Using Transcriptomic and Exome Profiling

Blood, 2020-11, Vol.136 (Supplement 1), p.16-17

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(50)

Sprache

Englisch
(50)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(10)
Klinická Onkologie
(4)
Cancers
(3)
Clinical Lymphoma, Myeloma And Leukemia
(3)
Embo Molecular Medicine
(2)
Hemasphere
(2)
Leukemia
(2)
Nature
(2)
Plos One
(2)
American Journal Of Hematology
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mechanism of phospho-ubiquitin-induced PARKIN activation

Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination

The deubiquitinase OTUD1 regulates immunoglobulin production and proteasome inhibitor sensitivity in multiple myeloma

Assembly and Specific Recognition of K29- and K33-Linked Polyubiquitin

Limited efficacy of daratumumab in multiple myeloma with extramedullary disease

Length-Dependent Translation Efficiency of ER-Destined Proteins

Multiple regulatory roles of the mouse transmembrane adaptor protein NTAL in gene transcription and mast cell physiology

Intercellular Mitochondrial Transfer in the Tumor Microenvironment

Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis

Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-ATPase ( PSMC ) Gene Family in the Light of Proteasome Inhibitor Resistance in Multiple Myeloma

P805: EXTRAMEDULLARY MULTIPLE MYELOMA: MOLECULAR PATHOGENESIS AND NOVEL THERAPEUTIC TARGETS

Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility

Venetoclax: A new wave in hematooncology

Deubiquitinase OTUD1 Resolves Stalled Translation on polyA and Rare Codon Rich mRNAs

Transcriptome Analysis of Diffuse Large B-Cell Lymphoma Cells Inducibly Expressing MyD88 L265P Mutation Identifies Upregulated CD44, LGALS3, NFKBIZ, and BATF as Downstream Targets of Oncogenic NF-κB Signaling

Loss of PPP2R2A inhibits homologous recombination DNA repair and predicts tumor sensitivity to PARP inhibition

The transmembrane adaptor protein NTAL signals to mast cell cytoskeleton via the small GTPase Rho

A Bird's-Eye View of Cell Sources for Cell-Based Therapies in Blood Cancers

Identification of Deubiquitinase OTUD1 As a Novel Player in Resistance of Multiple Myeloma to Bortezomib

Effect of Daratumumab-Containing Induction on CD34+ Hematopoietic Stem Cells before Autologous Stem Cell Transplantation in Multiple Myeloma

Active site alanine mutations convert deubiquitinases into high‐affinity ubiquitin‐binding proteins

Insight into the mechanism of CD34+ cell mobilisation impairment in multiple myeloma patients treated with anti‐CD38 therapy

Single‐agent venetoclax induces MRD‐negative response in relapsed primary plasma cell leukemia with t(11;14)

Selection, Expansion, and Unique Pretreatment of Allogeneic Human Natural Killer Cells with Anti-CD38 Monoclonal Antibody for Efficient Multiple Myeloma Treatment

Identification of Molecular Mechanisms Responsible for the Development of Extramedullary Disease in Myeloma and Potential Novel Therapeutic Targets Using Transcriptomic and Exome Profiling

Suchergebnisse filtern